Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Sells $46,823.95 in Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 8,885 shares of the company’s stock in a transaction dated Tuesday, October 31st. The stock was sold at an average price of $5.27, for a total transaction of $46,823.95. Following the transaction, the director now owns 7,416,305 shares in the company, valued at […]

Leave a Reply

Your email address will not be published.

Previous post Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Director Acquires $47,700.00 in Stock
Next post Celtics’ Jayson Tatum reflects on latest milestone, growing bond with Boston